BlackRock Fund Advisors’s Adamas Pharmaceuticals ADMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$14.4M Buy
854,745
+97,272
+13% +$1.5M ﹤0.01% 2365
2016
Q3
$12.4M Buy
757,473
+52,736
+7% +$802K ﹤0.01% 2338
2016
Q2
$10.7M Buy
704,737
+117,550
+20% +$1.94M ﹤0.01% 2377
2016
Q1
$8.49M Buy
587,187
+97,698
+20% +$1.65M ﹤0.01% 2454
2015
Q4
$13.9M Buy
489,489
+230,928
+89% +$3.89M ﹤0.01% 2259
2015
Q3
$4.33M Sell
258,561
-5,670
-2% -$129K ﹤0.01% 2869
2015
Q2
$6.93M Buy
264,231
+185,111
+234% +$3.6M ﹤0.01% 2717
2015
Q1
$1.38M Sell
79,120
-617
-0.8% -$10.6K ﹤0.01% 3187
2014
Q4
$1.39M Buy
79,737
+16,072
+25% +$244K ﹤0.01% 3202
2014
Q3
$1.19M Sell
63,665
-607
-0.9% -$10.4K ﹤0.01% 3182
2014
Q2
$1.18M Buy
+64,272
New +$1.15M ﹤0.01% 3155

Other funds holding ADMS